|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|
| OPERATING ACTIVITIES | ||||
| Net income | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and software amortization | ||||
| Net loss on securities available for sale | ||||
| Net gain on sale of other equity securities | ||||
| Net amortization of securities | ||||
| Amortization of core deposit intangible | ||||
| Provision for credit losses | ||||
| Loss on sale of foreclosed assets | ||||
| Deferred income taxes | ||||
| Net loss on sale of foreclosed assets | ||||
| Loss on sale of premises, equipment and software | ||||
| Stock-based compensation | ||||
| Net decrease in loans held for sale | ||||
| Income from bank owned life insurance | ||||
| Increase in interest receivable | ||||
| Increase in interest payable | ||||
| Net other operating activities | ||||
| Net cash provided by operating activities | ||||
| INVESTING ACTIVITIES | ||||
| Cash acquired in transaction | ||||
| Purchase of securities available for sale | ||||
| Purchase of other equity securities | ||||
| Proceeds from sale of securities available for sale | ||||
| Proceeds from sale of other equity securities | ||||
| Proceeds from maturities, calls, and paydowns of securities available for sale | ||||
| Net (purchase) redemption of restricted equity securities | ||||
| Net redemption (purchase) of restricted equity securities | ||||
| Purchase of annuities | ||||
| Purchase of bank owned life insurance | ||||
| Net increase in loans | ||||
| Proceeds from sale of foreclosed assets | ||||
| Proceeds from bank owned life insurance | ||||
| Purchase of premises, equipment and software | ||||
| Net cash used in investing activities | ||||
| FINANCING ACTIVITIES | ||||
| Net increase in deposits | ||||
| Net proceeds from issuance of common stock in connection with IPO | ||||
| Proceeds from issuance of common stock | ||||
| Proceeds from restricted stock units | ||||
| Repurchase of common stock | ||||
| Net proceeds (repayment) of FHLB advances | ||||
| Net repayments of FHLB advances | ||||
| Net proceeds from FHLB advances | ||||
| Net proceeds of note payable | ||||
| Net repayment of note payable | ||||
| Net repayment of other borrowings | ||||
| Net proceeds of other borrowings | ||||
| Net proceeds of subordinated notes | ||||
| Common stock dividends paid | ||||
| Net cash provided by financing activities | ||||
| Net increase in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of year | ||||
| Cash and cash equivalents at end of year | ||||
| SUPPLEMENTAL DISCLOSURE | ||||
| Cash paid during the year for: | ||||
| Interest | ||||
| Income taxes | ||||
| NONCASH TRANSACTIONS | ||||
| Transfers of loans to foreclosed assets | ||||
| Transfer of state and municipal available for sale securities to held to maturity securities | ||||
| Internally financed sales of foreclosed assets | ||||
Loading...
